Market Insights Health OTC Pharmaceuticals

Skin Treatment - Israel

Israel

In 2024, the revenue in the Skin Treatment market market in Israel amounts to US$67.92m.
It is projected to experience an annual growth rate of 5.55% (CAGR 2024-2029).
When compared to other countries globally, the in the United States generates the highest revenue, reaching US$4,184.00m in 2024.
In terms of per capita figures, each person in Israel generates revenues of US$7.29 in 2024.
Israel's skin treatment market is booming with a surge in demand for natural and organic products.

Key regions: Europe, United Kingdom, United States, Canada, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Skin Treatment market in Israel has been experiencing steady growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences: Customers in Israel have become increasingly conscious about their skin health and appearance, leading to a growing demand for skin treatments. This trend can be attributed to several factors, including the influence of social media and the desire to maintain a youthful and healthy appearance. Additionally, the Israeli population is aging, which has further fueled the demand for skin treatments as individuals seek to combat the signs of aging.

Trends in the market: One of the key trends in the Skin Treatment market in Israel is the rising popularity of non-invasive and minimally invasive procedures. Customers are increasingly opting for treatments such as laser therapy, chemical peels, and injectables, which offer effective results with minimal downtime. This trend can be attributed to the convenience and affordability of these procedures, as well as the growing awareness of their benefits.Another trend in the market is the increasing demand for natural and organic skin treatments. Customers in Israel are becoming more conscious about the ingredients used in skincare products and are seeking out natural and organic alternatives. This trend is driven by the growing awareness of the potential harmful effects of synthetic chemicals and the desire for more sustainable and environmentally-friendly options.

Local special circumstances: Israel's unique climate and geographical location also play a role in shaping the Skin Treatment market. The country experiences long periods of intense sunlight, which increases the risk of skin damage and accelerates the aging process. As a result, there is a high demand for treatments that can address sun damage and protect the skin from further harm. Additionally, Israel has a diverse population with different skin types and ethnic backgrounds, which creates a need for specialized treatments that cater to specific skin concerns.

Underlying macroeconomic factors: The growing Skin Treatment market in Israel can also be attributed to favorable macroeconomic factors. The country has a strong economy and a high standard of living, which enables individuals to invest in their personal well-being, including skincare treatments. Additionally, Israel has a well-developed healthcare system and a high level of technological advancement, which contributes to the availability of advanced skin treatments and attracts both local and international customers.In conclusion, the Skin Treatment market in Israel is experiencing growth due to changing customer preferences, including a focus on non-invasive and natural treatments. The country's unique climate and diverse population also contribute to the demand for specialized skincare solutions. Furthermore, favorable macroeconomic factors support the growth of the market, making Israel an attractive destination for skin treatment providers.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.